A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Agenus Inc.
National Cancer Institute (NCI)
ViroMissile, Inc.
MacroGenics
Avacta Life Sciences Ltd
Solve Therapeutics
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Degron Therapeutics Co.
University Health Network, Toronto
Blueprint Medicines Corporation
Actym Therapeutics, Inc.
City of Hope Medical Center
Institut Bergonié
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Numab Therapeutics AG
Baxter Healthcare Corporation
BeiGene
Shanghai PerHum Therapeutics Co., Ltd.
Pfizer
Adaptimmune
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Pfizer
Emory University
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
MacroGenics
Seagen Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tocagen Inc.
Mie University
Merrimack Pharmaceuticals
Corcept Therapeutics
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Shenzhen Second People's Hospital
Altor BioScience
Memorial Sloan Kettering Cancer Center